CFTR and lung disorder: Burgel and collaborators used a French compassionate program to assess for 4–6 weeks the effectiveness of ETI therapy in 84 PwCF (16 children and 68 adults) with advanced lung disease and carrying no F508del-CFTR in their alleles [60].